Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial
December 1, 2022
Second line GIST, no difference in OS or PFS between sunitinib and ripretinib, but ripretinib is more tolerable.
